Clinical Trial Update: Impact of the Oral Microbiota on Relapse in HNSCC Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the impact of the oral microbiota on relapse in patients with head and neck cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Institut Sainte Catherine | Conditions: Head and Neck Cancer | Phase 4 | Status: ACTIVE_NOT_RECRUITING